Apparent HIV-1 glycoprotein reactivity on western blot in uninfected blood donors. NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Apparent HIV-1 glycoprotein reactivity on western blot in uninfected blood donors.

AIDS. 1993 May;7(5):655-8. Unique Identifier : AIDSLINE MED/93305211
Healey DS; Bolton WV; National HIV Reference Laboratory, Fairfield Hospital, Victoria,; Australia.

Abstract: OBJECTIVES: To investigate samples with 'false-positive' reactivity to HIV-1 glycoproteins on Western blot (WB). DESIGN: Samples from 13 blood donors with glycoprotein reactivity were examined for serological evidence of HIV infection and followed-up where possible. METHODS: Samples were tested for anti-HIV-1, HIV-1 p24 antigen, anti-HIV-2 and anti-HTLV-1. Reactivity to multimeric, monomeric, and deglycosylated gp41 was determined, as was the ability of recombinant gp160 (rgp160) to inhibit reactivity to multimeric gp41. RESULTS: Serology and follow-up failed to confirm HIV infection in any of the donors. All samples reacted to multimeric gp41, and eight out of the 13 reacted to deglycosylated gp41. Reactivity on a commercial WB was inhibited by rgp160. CONCLUSION: Apparent reactivity to HIV-1 glycoprotein may occur in individuals with no other serological evidence of HIV infection. Reactivity to different forms of gp41 and inhibition by rgp160 suggested that the observed WB reactivity may be due to cross-reactivity with gp41 rather than to a co-migrating contaminant.
Keywords: AIDS Serodiagnosis/*METHODS *Blood Donors Blotting, Western Cross Reactions False Positive Reactions Gene Products, env/*IMMUNOLOGY Human HIV Antigens/*BLOOD HIV Envelope Protein gp41/IMMUNOLOGY HIV Seropositivity/BLOOD/DIAGNOSIS HIV-1/*IMMUNOLOGY Support, Non-U.S. Gov't JOURNAL ARTICLEKWDaidsserodiagnosis/KWDmethodsKWDblooddonorsblotting,westerncrossreactionsfalsepositivereactionsgeneproducts,env/KWDimmunologyhumanhivantigens/KWDbloodhivenvelopeproteingp41/immunologyhivseropositivity/blood/diagnosishiv-1/KWDimmunologysupport,non-uKWDsKWDgov'tjournalarticle
931030
M93A0747

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .